Öğr. Gör. Dr. KADER ÇİÇEK

Yayın Ağı

Makaleler 6

1. Mechanism of acquired resistance to histone deacetylase inhibitor, romidepsin, in myeloid leukemia associated with down syndrome

Cicek K., Faust J., Barwe S., Gopalakrishnapillai A.

BLOOD , cilt.146, ss.1512, 2025 (SCI-Expanded, Scopus)

2. Regulation of Molecular Targets in Osteosarcoma Treatment

Celik B., Cicek K., Leal A. F., Tomatsu S.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES , cilt.23, sa.20, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

3. Tumor-B-cell interactions promote isotype switching to an immunosuppressive IgG4 antibody response through upregulation of IL-10 in triple negative breast cancers

Toney N. J., Opdenaker L. M., Cicek K., Frerichs L., Kennington C. R., Oberly S., et al.

JOURNAL OF TRANSLATIONAL MEDICINE , cilt.20, sa.1, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

4. **A Plant-Produced in vivo deglycosylated full-length Pfs48/45 as a Transmission-Blocking Vaccine Candidate against malaria**

Mamedov T., ÇİÇEK K., Miura K., Gulec B., Akinci E., Mammadova G., et al.

SCIENTIFIC REPORTS , cilt.9, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

5. **Engineering, and production of functionally active human Furin in N. benthamiana plant: In vivo post-translational processing of target proteins by Furin in plants**

Mamedov T., Musayeva I., Acsora R., Gun N., Gulec B., Mammadova G., et al.

PLOS ONE , cilt.14, sa.3, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

6. ***In vivo* production of non-glycosylated recombinant proteins in Nicotiana benthamiana plants by co-expression with Endo-β-N-acetylglucosaminidase H (Endo H) of *Streptomyces plicatus***

Mamedov T., ÇİÇEK K., Gulec B., Ungor R., Hasanova G.

PLOS ONE , cilt.12, sa.8, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 3

1. DYRKIA interacts with EZH2 to regulate transcriptionally active chromatin in myeloid leukemia associated with down syndrome

Cicek K., Barwe S., Gopalakrishnapillai A.

67th Annual Meeting of the American-Society-of-Hematology (ASH), Florida, Amerika Birleşik Devletleri, 6 - 09 Aralık 2025, cilt.146, ss.5072, (Özet Bildiri)

2. BTK regulates EZH2 stability in myeloid leukemia associated with down syndrome

Cicek K., Tavenner M., Barwe S., Gopalakrishnapillai A.

67th Annual Meeting of the American-Society-of-Hematology (ASH), Florida, Amerika Birleşik Devletleri, 6 - 09 Aralık 2025, cilt.146, ss.5071, (Özet Bildiri)

3. Preclinical Validation of EZH2 and HDAC I Dual Inhibition As a Potent Therapy for Refractory Myeloid Leukemia Associated with Down Syndrome

Cicek K., Faust J. R., Tavenner M., Kolb E. A., Barwe S. P., Gopalakrishnapillai A.

64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Louisiana, Amerika Birleşik Devletleri, 10 - 13 Aralık 2022, cilt.140, ss.5951-5952, (Özet Bildiri) Sürdürülebilir Kalkınma

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

101

H-İndeks (Scopus)

BM Sürdürülebilir Kalkınma Amaçları